Literature DB >> 26421442

Coordinate Activation of Redox-Dependent ASK1/TGF-β Signaling by a Multiprotein Complex (MPK38, ASK1, SMADs, ZPR9, and TRX) Improves Glucose and Lipid Metabolism in Mice.

Hyun-A Seong1, Ravi Manoharan1, Hyunjung Ha1.   

Abstract

AIMS: To explore the molecular connections between redox-dependent apoptosis signal-regulating kinase 1 (ASK1) and transforming growth factor-β (TGF-β) signaling pathways and to examine the physiological processes in which coordinated regulation of these two signaling pathways plays a critical role.
RESULTS: We provide evidence that the ASK1 and TGF-β signaling pathways are interconnected by a multiprotein complex harboring murine protein serine-threonine kinase 38 (MPK38), ASK1, Sma- and Mad-related proteins (SMADs), zinc-finger-like protein 9 (ZPR9), and thioredoxin (TRX) and demonstrate that the activation of either ASK1 or TGF-β activity is sufficient to activate both the redox-dependent ASK1 and TGF-β signaling pathways. Physiologically, the restoration of the downregulated activation levels of ASK1 and TGF-β signaling in genetically and diet-induced obese mice by adenoviral delivery of SMAD3 or ZPR9 results in the amelioration of adiposity, hyperglycemia, hyperlipidemia, and impaired ketogenesis. INNOVATION AND
CONCLUSION: Our data suggest that the multiprotein complex linking ASK1 and TGF-β signaling pathways may be a potential target for redox-mediated metabolic complications.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26421442     DOI: 10.1089/ars.2015.6325

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  8 in total

1.  Healthy diet is associated with gene expression in blood: the Framingham Heart Study.

Authors:  Honghuang Lin; Gail T Rogers; Kathryn L Lunetta; Daniel Levy; Xiao Miao; Lisa M Troy; Paul F Jacques; Joanne M Murabito
Journal:  Am J Clin Nutr       Date:  2019-09-01       Impact factor: 7.045

2.  Zinc finger protein ZPR9 functions as an activator of AMPK-related serine/threonine kinase MPK38/MELK involved in ASK1/TGF-β/p53 signaling pathways.

Authors:  Hyun-A Seong; Ravi Manoharan; Hyunjung Ha
Journal:  Sci Rep       Date:  2017-02-14       Impact factor: 4.379

3.  Smad proteins differentially regulate obesity-induced glucose and lipid abnormalities and inflammation via class-specific control of AMPK-related kinase MPK38/MELK activity.

Authors:  Hyun-A Seong; Ravi Manoharan; Hyunjung Ha
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

4.  Thr55 phosphorylation of p21 by MPK38/MELK ameliorates defects in glucose, lipid, and energy metabolism in diet-induced obese mice.

Authors:  Hyun-A Seong; Hyunjung Ha
Journal:  Cell Death Dis       Date:  2019-05-16       Impact factor: 8.469

5.  Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer.

Authors:  Carlos Perez Kerkvliet; Amy R Dwyer; Caroline H Diep; Robert H Oakley; Christopher Liddle; John A Cidlowski; Carol A Lange
Journal:  Breast Cancer Res       Date:  2020-05-01       Impact factor: 6.466

6.  EM23, A Natural Sesquiterpene Lactone from Elephantopus mollis, Induces Apoptosis in Human Myeloid Leukemia Cells through Thioredoxin- and Reactive Oxygen Species-Mediated Signaling Pathways.

Authors:  Hongyu Li; Manmei Li; Guocai Wang; Fangyuan Shao; Wenbo Chen; Chao Xia; Sheng Wang; Yaolan Li; Guangxiong Zhou; Zhong Liu
Journal:  Front Pharmacol       Date:  2016-03-29       Impact factor: 5.810

Review 7.  Redox regulation in tumor cell epithelial-mesenchymal transition: molecular basis and therapeutic strategy.

Authors:  Jingwen Jiang; Kui Wang; Yan Chen; Haining Chen; Edouard C Nice; Canhua Huang
Journal:  Signal Transduct Target Ther       Date:  2017-08-18

8.  MELK expression correlates with tumor mitotic activity but is not required for cancer growth.

Authors:  Christopher J Giuliano; Ann Lin; Joan C Smith; Ann C Palladino; Jason M Sheltzer
Journal:  Elife       Date:  2018-02-08       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.